Literature DB >> 10574273

Pharmacokinetics of florfenicol after treatment of pigs with single oral or intramuscular doses or with medicated feed for three days.

J Voorspoels1, E D'Haese, B A De Craene, C Vervaet, D De Riemaecker, P Deprez, H Nelis, J P Remon.   

Abstract

The pharmacokinetics of florfenicol, a structural analogue of thiamphenicol, were studied in six pigs after single oral and intramuscular doses of 15 mg/kg bodyweight, and after feeding them with medicated feed containing 250 mg/kg for three days, a concentration which provided approximately the same dose rate of the drug. The oral doses contained a specially prepared pelleted formulation of the drug. The bioavailability of the drug was similar for the oral and intramuscular doses. Florfenicol was absorbed rapidly from the feed and its concentration in plasma remained between 2 and 6 microg/ml - above the minimum inhibitory concentration values for common pig pathogens - during the three days.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10574273     DOI: 10.1136/vr.145.14.397

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  8 in total

1.  Tissue pharmacokinetics of florfenicol in pigs experimentally infected with Actinobacillus pleuropneumoniae.

Authors:  Jian-Zhong Li; Ki-Fai Fung; Zhang-Liu Chen; Zhen-Ling Zeng; Jie Zhang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Oct-Dec       Impact factor: 2.441

2.  Pharmacokinetics of florfenicol in healthy pigs and in pigs experimentally infected with Actinobacillus pleuropneumoniae.

Authors:  Jianzhong Liu; Ki-Fai Fung; Zhangliu Chen; Zhenling Zeng; Jie Zhang
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

3.  Comparative plasma pharmacokinetics and tolerance of florfenicol following intramuscular and intravenous administration to camels, sheep and goats.

Authors:  B H Ali; A A Al-Qarawi; M Hashaad
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

4.  Pattern of Antibiotic Consumption in Two Italian Production Chains Differing by the Endemic Status for Porcine Reproductive and Respiratory Syndrome.

Authors:  Paolo Trevisi; Laura Amatucci; Roberta Ruggeri; Costanza Romanelli; Giampietro Sandri; Diana Luise; Massimo Canali; Paolo Bosi
Journal:  Front Vet Sci       Date:  2022-03-28

5.  An Interactive Generic Physiologically Based Pharmacokinetic (igPBPK) Modeling Platform to Predict Drug Withdrawal Intervals in Cattle and Swine: A Case Study on Flunixin, Florfenicol, and Penicillin G.

Authors:  Wei-Chun Chou; Lisa A Tell; Ronald E Baynes; Jennifer L Davis; Fiona P Maunsell; Jim E Riviere; Zhoumeng Lin
Journal:  Toxicol Sci       Date:  2022-07-28       Impact factor: 4.109

6.  PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs.

Authors:  Zhixin Lei; Qianying Liu; Shuaike Yang; Bing Yang; Haseeb Khaliq; Kun Li; Saeed Ahmed; Abdul Sajid; Bingzhou Zhang; Pin Chen; Yinsheng Qiu; Jiyue Cao; Qigai He
Journal:  Front Pharmacol       Date:  2018-01-17       Impact factor: 5.810

7.  Similar Gastro-Intestinal Exposure to Florfenicol After Oral or Intramuscular Administration in Pigs, Leading to Resistance Selection in Commensal Escherichia coli.

Authors:  Joren De Smet; Filip Boyen; Siska Croubels; Geertrui Rasschaert; Freddy Haesebrouck; Patrick De Backer; Mathias Devreese
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

8.  Synovial and Systemic Pharmacokinetics of Florfenicol and PK/PD Integration against Streptococcus suis in Pigs.

Authors:  Zoltán Somogyi; Patrik Mag; Dóra Kovács; Ádám Kerek; Pál Szabó; László Makrai; Ákos Jerzsele
Journal:  Pharmaceutics       Date:  2022-01-03       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.